Article information
Full text is only available in PDF
Bibliografía
[1.]
A.D. Lopez, C.C.J.L. Murray.
The global burden of disease, 1990- 2020.
Nature Med, 4 (1999), pp. 1241-1243
[2.]
P.S. Burge.
EUROSCOP, ISOLDE and the Copenhagen City Lung Study.
Thorax, 1999 (1999), pp. 287-288
[3.]
F. Morell, A. Roman, C. Bravo, F. Nicolau, S. Marti.
Resultados de la evaluacion de los 208 pacientes remitidos en los primeros 4 anos a un programa de trasplante pulmonar.
Arch Bronconeumol, 32 (1996), pp. 280-284
[4.]
J.D. Hosenpud, L.E. Bennett, B.M. Keck, E.B. Edwards, R.J. Novick.
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.
Lancet, 351 (1998), pp. 24-27
[5.]
J.D. Cooper, E.P. Trulock, A.N. Triantafillou.
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease.
J Thorac Cardiovasc Surg, 109 (1995), pp. 106-119
[6.]
H.E. Fessler, R.A. Wise.
Lung volume reduction surgery.Is less really more?.
Am J Respir Crit Care Med, 159 (1999), pp. 1031-1035
[7.]
Y. Lacasse, E. Wong, G.H. Guyatt, D. King, D.J. Cook, R.S. Goldstein.
Metaanalysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
Lancet, 348 (1996), pp. 1115-1119
[8.]
T.L. Griffiths, M.L. Burr, I.A. Campbell, V. Lewis-Jenkins, J. Mullins, K. Shiels, et al.
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.
Lancet, 355 (2000), pp. 362-368
[9.]
A.G.N. Agusti, A. Noguera, J. Sauleda, B. Togores.
Nuevas perspectivas en el manejo de la EPOC.
Rev Patol Respir, 1 (2000), pp. 44-53
[10.]
A.M. Schols, J. Slangen, L. Volovics, E.F. Wouters.
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 1791-1797
[11.]
American ThoracicSociety Society,European Respiratory Society.
Skeletal muscle dysfunction in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 159 (1999), pp. S1-S40
[12.]
A.G.N. Agusti, A. Noguera, J. Sauleda, C. Miralles, S. Batlle, X. Busquets.
Systemic inflammation in chronic respiratory diseases.
Eur Respir Monogr, (2000),
[13.]
B. Celli, C. Cote, J. Marin, M. Montes de Oca, C. Casanova, M.R. Mendez.
The SCORE: a new COPD staging system combining 6MWD, MRD dyspnea, FEV1 and PaO2 as predictors of health care resources utilization (HCRU).
Am J Respir Crit Care Med, 161 (2000), pp. A749
[14.]
T. Montemayor, I. Alfajame, C. Escudero, J. Morera, L. Sanchez.
Normativa sobre diagnostico y tratamiento de la enfermedad pulmonar obstructiva cronica.
Arch Bronconeumol, 32 (1996), pp. 285-301
[15.]
P.M. Meek, R.M. Schwartzstein, L. Adams, M.D. Altose, E.H. Breslin, V. Carrieri-Kohlman, et al.
Dyspnea.
Am J Respir Crit Care Med, 159 (1999), pp. 321-340
[16.]
B. Burrows, R.J. Knudson, M.G. Cline.
Quantitative relationships between cigarette smoking and ventilatory function.
Am Rev Respir Dis, 115 (1977), pp. 195-205
[17.]
C. Fletcher, R. Peto.
The natural history of chronic airflow obstruction.
Br Med J, 1 (1977), pp. 1645-1648
[18.]
E.K. Silverman, F.E. Speizer.
Risk factors for the development of chronic obstructive pulmonary disease.
Med Clin North Am, 80 (1996), pp. 501-522
[19.]
A.J. Sanford, T.D. Weir, J.J. Spinelli, P.D. Pare.
Z and S mutations of the ?á1-antitrypsin gene and the risk of chronic obstructive pulmonary disease.
Am J Respir Cell Mol Biol, 20 (1999), pp. 287-291
[20.]
E.K. Silverman, H.A. Chapman, J.M. Drazen, S.T. Weiss, B. Rosner, E.J. Campbell, et al.
Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease . Risk to relatives for airflow obstruction and chronic bronchitis.
Am J Respir Crit Care Med, 157 (1998), pp. 1770-1778
[21.]
P.J. Barnes.
Molecular genetics of chronic obstructive pulmonary disease.
Thorax, 54 (1999), pp. 245-252
[23.]
D.S. Jorenby, S. Leischow, A. Nides, S. Rennard, J.A. Johnston, et al.
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
N Engl J Med, 340 (1999), pp. 685-691
[24.]
P.W. Jones, T.K. Bosh.
Improvement in quality of life in COPD patients treated with salmeterol.
Am J Respir Crit Care Med, 151 (1995), pp. A464
[25.]
D.A. Mahler, J.F. Donohue, Barbee, R.A.M.D. Goldman, N.J. Gross, M.E. Wisniewski, et al.
Efficacy of salmeterol xinafoate in the treatment of COPD.
Chest, 115 (1999), pp. 957-965
[26.]
B. Disse, G.A. Speck, K.L. Rominger, J.r. Witek TJ, R. Hammer.
Tiotropium (SpirivaTM): mechanistical considerations and clinical profile in obstructive lung disease.
Life Sci, 64 (1999), pp. 457-464
[27.]
P.S. Burger, P.M. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, T.K. Maslen.
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.
Br Med J, 320 (2000), pp. 1297-1303
[28.]
P.J. Barnes.
New therapies for chronic obstructive pulmonary disease.
Thorax, 53 (1998), pp. 137-147
[29.]
A.F. Massaro, D. Massaro.
Retinoic acid treatment abrogates elastase- induced pulmonary emphysema in rats.
Nature Med, 6 (1997), pp. 675-677
[30.]
J.T. Mao, D. Aberle, D.P. Tashkin, J. Goldin.
A phase II pilot study of all-trans retinoic acid for the treatment of human emphysema.
Am J Respir Crit Care Med, 161 (2000), pp. A583
[31.]
I.M. Ferreira, D. Brooks, Y. Lacasse, R.S. Goldstein.
Nutritional support for individuals with COPD: a meta-analysis.
Chest, 117 (2000), pp. 672-678
[32.]
F. Barbe, A.G.N. Agusti.
Ventilacion nasal en la EPOC agudizada.
Arch Bronconeumol, 30 (1994), pp. 475-476
[33.]
A.G.N. Agusti, F. Barbe, B. Togores.
Non invasive ventilation.
N Engl J Med, 338 (1998), pp. 1388-1389
[34.]
J. Bott, M.P. Carroll, J.H. Conway, S.E.J. Keilty, E.M. Ward, A.M. Brown, et al.
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease.
Lancet, 341 (1993), pp. 1555-1557
[35.]
L. Brochardg, J. Mancebo, M. Wysocki, F. Lofaso, G. Conti, A. Rauss, et al.
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
N Engl J Med, 333 (1995), pp. 817-822
[36.]
N. Kramer, T.J. Meyer, J. Meharg, R.D. Cece, N.S. Hill.
Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure.
Am J Respir Crit Care Med, 151 (1995), pp. 1799-1806
[37.]
F. Barbé, B. Togores, M. Rubí, S. Pons, A. Maimó, A.G.N. Agustí.
Non-invasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease.
Eur Respir, 9 (1996), pp. 1240-1245
[38.]
C.C. Lin.
Comparison between nocturnal nasal positive pressure ventilation combined with oxygen therapy and oxygen monotherapy in patients with severe COPD.
Am J Respir Crit Care Med, 154 (1996), pp. 353-358
[39.]
D.J. Meecham Jones, E.A. Paul, P.W. Jones, J.A. Wedzicha.
Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD.
Am J Repir Crit Care Med, 152 (1995), pp. 538-544
[40.]
E.P. Ingenito, J.J. Reily, K.R. Lutchen, R. Vin, S. Swanson, S. Mentzer, et al.
Bronchoscopic volume reduction: an effective and safe alternative to surgical therapy.
Am J Respir Crit Care Med, 161 (2000), pp. A750
[41.]
R. Güell, A. González, F. Morante, M. Sangenís, C. Sotomayor, C. Caballero, et al.
Mejor en casa: un programa de asistencia continuada para los pacientes con enfermedad respiratoria crónica avanzada.
Arch Bronconeumol, 34 (1998), pp. 541-546
[42.]
J.H. Gravil, O.A. Al-rawas, M.M. Cotton, U. Flanigan, A. Irwin, R.D. Stevenson.
Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service.
Lancet, 351 (1998), pp. 1853-1855
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica
